Saarland business and science delegation to visit next week

Four managers of nanotechnology companies will discuss possible joint projects with Israeli companies and research institutes.

A delegation of industrialists and scientists from Saarland, Germany will visit Israel next week to discuss possible joint projects with Israeli companies and research institutes.

Saarland Business Development Authority chairman Thomas Schuck will head the delegation, accompanied by four managers of nanotechnology companies that develop and manufacture a range of products.

The companies' products are applied in several industries, including cosmetics; pharmaceuticals; antirust and anti-scratch coatings for the automobile, steel, aluminum and aeronautics industries, and anti-bacteriological coatings for the medical devices industry.

Saarland Business Development Authority representative in Israel Dov Raviv said Saarland was an important European center for biotechnology and nanotechnology, and that it was investing in developing academic, commercial and business ties with Israel.

A number of Israeli companies are active in Saarland, utilizing state incentives for investors, and exploiting the state's rapid access to continental distribution networks to the neighboring countries of France, Luxembourg and Belgium.

Published by Globes [online] - www.globes.co.il - on November 22, 2004

5 Comments
View comments in rows
Update by email about comments talkback
POST
Comments
Your name
Please insert your name
Content
Hyperlink in a new window Hyperlink Right Left underline italic bold Bulleted List Ordered List Face1 Face2 Face3 Face4 Face5 Face6
Your comment

Thanks
You comment was recieved and soon will be published.
In posting comments, I agree to abide by the Terms of Use
Globes encourages lively and frank debate, but posts that the editors consider merely abusive or otherwise inappropriate will be removed. Report inappropriate content
Thank you for posting your comment, which will be reviewed for publication.
Loading Comments...load
Load more comments
Twitter Facebook Linkedin RSS Newsletters גלובס